Pure Eyes Sterile Eyes Naphazoline Hydrochloride and Glycerin .1 mg/mL; 2.5 mg/mL Solution/ Drops — NDC 20146-7000-1 (Billing 20146-7000-01)
This is a package of Pure Eyes Sterile Eyes Naphazoline Hydrochloride and Glycerin .1 mg/mL; 2.5 mg/mL Solution/ Drops from SAMSON PHARMACEUTICAL, first listed with the FDA Jan 2015 and currently FDA-listed. It is this product's only package size.
NDC database record
One package, one record: these facts belong to NDC 20146-7000-1 alone.
- Record
- FDA NDC Directory package listing · Human OTC drug
- Code segments
- 20146 labeler · 7000 product · 1 package
- Package marketed since
- Jan 1, 2015
- Sample package
- No — commercial package
- Listing certified through
- Dec 31, 2027
- Barcode (UPC)
- 0610466049750
- FDA record last changed
- Aug 27, 2026
Other active recalls for Naphazoline Hydrochloride And Glycerin (different manufacturers) — 2 · tap to view
Identity & classification
Regulatory identifiers FDA, NLM and CMS codes for this package
- RxCUI (RxNorm): 1046700
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- FDA label on DailyMed · label index refreshed Nov 20, 2026
- RxNorm (NLM RxNav) · catalog refreshed Nov 19, 2026
- Medi-Span GPI (licensed)
- First Databank (licensed) · refreshed Nov 19, 2026
RxNorm drug class
This medicine belongs to the Non-Standardized Chemical Allergen class.
Where does this data come from?
- RxClass (NLM) · catalog refreshed Nov 19, 2026
Clinical
Pure Eyes Sterile Eyes is an over-the-counter eye drop solution containing naphazoline hydrochloride and glycerin. Naphazoline hydrochloride is a decongestant typically used to reduce redness and relieve minor eye irritation. Glycerin functions as a lubricant and helps protect the eye surface. This product is marketed as an OTC monograph drug, meaning it follows FDA's established safety and use guidelines for this class of eye drops.
Patient education
Supplement & herbal interactions
Where does this data come from?
- MedlinePlus (NLM) · refreshed Nov 19, 2026
- FDA label on DailyMed · label index refreshed Nov 20, 2026
Ask a licensed pharmacist directly — free, answered by our team.
Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per mL | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
Where does this data come from?
- CMS NADAC weekly file
- CMS ASP pricing files · refreshed Nov 20, 2026
- CMS Medicaid State Drug Utilization Data · refreshed Nov 19, 2026
- CMS Part D plan pricing files · refreshed Oct 24, 2026
- VA National Acquisition Center price file
Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Marketing end | Status |
|---|---|---|---|---|
| 20146-7000-01 You're viewing this Main listing | 1 BOTTLE in 1 BLISTER PACK / 7 mL in 1 BOTTLE | 2015-01-01 | — | Active |
Therapeutic equivalents
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- FDA Orange Book · refreshed Nov 6, 2026
- CMS NADAC weekly file
Availability & generic status
We did not find an FDA-approved generic match for this exact strength, form and route.
Where does this data come from?
- FDA Orange Book · refreshed Nov 6, 2026
Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.
-
UNII F5UM2KM3W7
Benzalkonium chloride is a chemical compound that works as a preservative and antimicrobial agent in medications. It prevents bacterial and fungal growth in liquid formulations to keep the product safe during storage and use.
-
UNII R57ZHV85D4
Boric acid is a weak acid derived from boron. In medicines, it typically serves as a buffer to help maintain the product's pH level and may act as a preservative in certain formulations.
-
UNII 7FLD91C86K
Edetate disodium is a chemical compound that binds and removes certain metal ions. In medicines, it acts as a preservative and stabilizer by preventing metals like calcium from interfering with the product's shelf life and consistency.
-
UNII 91MBZ8H3QO
Sodium borate is an inorganic salt compound used in medicines as a buffer to help maintain a stable pH level, and sometimes as a mild preservative or cleansing agent in topical formulations.
-
UNII 059QF0KO0R
Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.
5 inactive ingredients listed in the exact product block matched to this NDC.
Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.
Where does this data come from?
ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.- FDA label on DailyMed · label index refreshed Nov 20, 2026
- FDA openFDA NDC Directory · synced Nov 19, 2026
Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
Why might an inactive ingredient be missing?
Can inactive ingredients matter?
Manufacturer & labeler
More NDCs from SAMSON PHARMACEUTICAL labeler code 20146
- LA Bodies Eclipse Sunscreen SPF 30 Avobenzone, Homosalate, Octisalate, Octocrylene, and Oxybenzone 20 mg/g; 130 mg/g; 50 mg/g; 20 mg/g; 40 mg/g Lotion NDC 20146-4007-1
- LA Bodies Eclipse Sunscreen SPF 50 Avobenzone, Homosalate, Octisalate, Octocrylene, and Oxybenzone 30 mg/g; 150 mg/g; 50 mg/g; 24 mg/g; 60 mg/g Lotion NDC 20146-4008-1
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- Drugs@FDA
FDA label — Drug Facts FDA SPL
🎯 Indications and Usage ▾
Uses ♦ Relieve redness of the eye due to minor irritation ♦ Temporary relief of burning and irritation due to dryness of the eye ♦ Protects against further irritation
⏱️ Dosage and Administration ▾
Directions ♦ Instill 1 to 2 drops in the affected eye(s) up to 4 times daily
⚠️ Warnings ▾
Warnings For external use only Do not use if solution changes color or becomes cloudy Ask a doctor before use if you have ♦ Narrow angle glaucoma When using this product ♦ Do not touch tip of container to any surface to avoid contamination ♦ Do not overuse as it may products increased redness of the eye ♦ Pupils may be come enlarged temporarily ♦ Remove contact lenses before using ♦ Replace cap after use Stop use and ask a doctor if ♦ You experience eye pain, changes in vision, continued redness or irritation of the eyes ♦ Conditions worsens or persists for more than 72 hours Keep put of reach of children.
Id swallowed, get medical help or contact a Poison Control Center right away.
📦 Storage and Handling ▾
Other information ♦ Store at 15- 30 C (59-86 F) ♦ Keep tightly closed ♦ Use before expiration date marked on the carton and bottle ♦ Serious side effect associated with use of the product may be reported to the phone number provided below
🧪 Active Ingredient ▾
ACTIVE INGREDIENTS PURPOSE Naphazoline HCL 0.01% Redness reliever Glycerin 0.25% Lubricant
🧪 Inactive Ingredients ▾
Inactive ingredients benzalkonium chloride, boric acid, edetate disodium, purified water, sodium borate.
🎯 Purpose ▾
ACTIVE INGREDIENTS PURPOSE Naphazoline HCL 0.01% Redness reliever Glycerin 0.25% Lubricant
📄 Do Not Use ▾
Do not use if solution changes color or becomes cloudy
📄 Ask a Doctor Before Use If ▾
Ask a doctor before use if you have ♦ Narrow angle glaucoma
📄 When Using This Product ▾
When using this product ♦ Do not touch tip of container to any surface to avoid contamination ♦ Do not overuse as it may products increased redness of the eye ♦ Pupils may be come enlarged temporarily ♦ Remove contact lenses before using ♦ Replace cap after use
📄 Stop Use and Ask a Doctor If ▾
Stop use and ask a doctor if ♦ You experience eye pain, changes in vision, continued redness or irritation of the eyes ♦ Conditions worsens or persists for more than 72 hours
📄 Keep Out of Reach of Children ▾
Keep put of reach of children. Id swallowed, get medical help or contact a Poison Control Center right away.
📄 Questions or Comments ▾
Question? 1-888-995-9935
📄 Package Label / Principal Display Panel ▾
PRINCIPAL DISPLAY PANEL - 7 mL Bottle Blister Pack POCKET SIZE MAXIMUM REDNESS RELIEF Pure Eyes ® STERILE EYE DROPS ✓ Relieves ✓ Protects ✓ Soothes ✓ Moisturizes Made in the U.S.A.
0.24 FL OZ (7ML) Principal Display Panel - 7 mL Bottle Blister Pack
Reported adverse events (FAERS)
Top reported reactions
Reporter sex
Serious outcomes
Where does this data come from?
About this NDC listing & data coverage
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | ✓ Available |
| Inactive ingredients (structured) | ✓ Available |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |